GE wins clearance for third digital x-ray unitAlmost a year after gaining clearance for its digital chest x-ray system, Revolution XQ/i, GE Medical Systems has received the go-ahead for a general-purpose unit based on the same detectors. On Oct.
Almost a year after gaining clearance for its digital chest x-ray system, Revolution XQ/i, GE Medical Systems has received the go-ahead for a general-purpose unit based on the same detectors. On Oct. 12, the Food and Drug Administration cleared Revolution TX/i, a general radiography system, according to Milwaukee-based GE. The unit joins the companys three other digital offerings: Revolution XQ/i; SenoVision, its digital spot and stereotactic system; and Senographe 2000D, its full-field mammography product, which is cleared for sale in Europe but not in the U.S.
Revolution TX/i boasts a flat-panel, amorphous silicon cesium iodide detector that measures 41 x 41 cm and is manufactured from a single seamless thin-film-transistor array. Although it uses the same detector as XQ/i, Revolution TX/i is configured slightly differently than the chest unit, consisting of a table for general radiography work with the chest stand as an option, according to Kevin Hobert, global manager of digital x-ray and installed base. The unit is now in the early clinical trial stage, but GE plans to begin full production early next year. The system will sell for $400,000 to $650,000, depending on configuration.
Can AI Facilitate Improved Dual-Energy X-Ray Screening for Patients at High Risk of Osteoporosis?
June 28th 2024Out of 315 patients identified by artificial intelligence (AI) as being at high risk for osteoporosis, subsequent screening with dual-energy X-ray absorptiometry (DXA) in a randomized controlled trial revealed new-onset osteoporosis in 237 patients.
FDA Clears Mobile C-Arm Device Designed for Complex Vascular Procedures
June 17th 2024Offering a combination of intuitive user-friendly controls and enhanced imaging, the Zenition 90 Motorized C-arm reportedly facilitates workflow efficiencies and bolsters visualization for complex vascular procedures, cardiac interventions, and other clinical procedures.
Qure.ai to Debut Multimodality AI Platform for Lung Cancer Imaging at ASCO 2024
May 29th 2024In addition to detecting missed lung nodules on X-rays, the AI-powered Qure.ai lung cancer continuum platform reportedly automates lung nodule measurement on CT scans and facilitates multimodality reporting.